Cargando…
Diversity of the Senescence Phenotype of Cancer Cells Treated with Chemotherapeutic Agents
It is acknowledged that cancer cells are able to undergo senescence in response to clinically used chemotherapeutics. Moreover, recent years have provided evidence that some drugs can selectively remove senescent cells. Therefore, it is essential to properly identify and characterize senescent cells...
Autores principales: | Bojko, Agnieszka, Czarnecka-Herok, Joanna, Charzynska, Agata, Dabrowski, Michal, Sikora, Ewa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6952928/ https://www.ncbi.nlm.nih.gov/pubmed/31771226 http://dx.doi.org/10.3390/cells8121501 |
Ejemplares similares
-
Therapy-Induced Senescent/Polyploid Cancer Cells Undergo Atypical Divisions Associated with Altered Expression of Meiosis, Spermatogenesis and EMT Genes
por: Czarnecka-Herok, Joanna, et al.
Publicado: (2022) -
Improved Autophagic Flux in Escapers from Doxorubicin-Induced Senescence/Polyploidy of Breast Cancer Cells
por: Bojko, Agnieszka, et al.
Publicado: (2020) -
Chromatin-Directed Proteomics Identifies ZNF84 as a p53-Independent Regulator of p21 in Genotoxic Stress Response
por: Strzeszewska-Potyrała, Anna, et al.
Publicado: (2021) -
Insight into the role of PIKK family members and NF-кB in DNAdamage-induced senescence and senescence-associated secretory phenotype of colon cancer cells
por: Strzeszewska, Anna, et al.
Publicado: (2018) -
Curcumin induces multiple signaling pathways leading to vascular smooth muscle cell senescence
por: Grabowska, Wioleta, et al.
Publicado: (2019)